Počet záznamov: 1
Activity and safety of crizotinib in patients with alveolar soft part sarcoma with rearrangement of TFE3. European Organization for Research and Treatment of Cancer (EORTC) phase 2 trial 90101 "CREATE"
- Activity and safety of crizotinib in patients with alveolar soft part sarcoma with rearrangement of TFE3. European Organization for Research and Treatment of Cancer (EORTC) phase 2 trial 90101 "CREATE" / Sufliarsky J. ... [et al.] . Onkológia. - ISSN 1336-8176 . - Roč. 12, č. 6 (2017), s. 453
- C 3069
článok
Počet záznamov: 1